BACKGROUND:The objective of this study is to describe incidence and shifts of serotype and clonal distribution of invasive Streptococcus pneumoniae strains in four different age groups (65 years) during a period of intermediate PCV13 vaccination coverage (2011-2016) in Catalonia, Spain. METHODS:We included all pneumococcal strains systematically sent to the Catalan support laboratory for molecular surveillance of invasive pneumococcal disease (IPD) located at Hospital Sant Joan de Deu, Barcelona. Two study periods were considered: 2011-13, early PCV13 vaccination period (EVP) and 2014-2016, late vaccination period (LVP). RESULTS:A total of 2142 strains were included in the study. Five years after intermediate introduction of PCV13 in our po...
Streptococcus pneumoniae serotype 1 (ST1) was an important cause of invasive pneumococ-cal disease (...
Streptococcus pneumoniae serotype 1 (ST1) was an important cause of invasive pneumococcal disease (I...
SummaryObjectivesTo describe the distribution of vaccine and non-vaccine pneumococcal serotypes from...
Background: The objective of this study is to describe incidence and shifts of serotype and clonal d...
The aim of this study was to study the serotypes and clonal diversity of pneumococci causing invasiv...
The goal of this study was to investigate the distribution of serotypes and clonal composition of St...
Serotypes/genotypes causing invasive pneumococcal disease (IPD) in adults are determined by vaccinat...
Background: Recently, the 13-valent pneumococcal conjugate vaccine (PCV13) has been recommended for ...
AbstractThe implementation of the seven-valent pneumococcal conjugate vaccine, PCV7, has resulted in...
<div><p>A prospective laboratory-based multicenter study that collected all adult invasive pneumococ...
A prospective laboratory-based multicenter study that collected all adult invasive pneumococcal dise...
AbstractThe present study evaluated changes in the incidence of invasive pneumococcal disease (IPD) ...
Streptococcus pneumoniae serotype 1 (ST1) was an important cause of invasive pneumococcal disease (I...
Streptococcus pneumoniae serotype 1 (ST1) was an important cause of invasive pneumococcal disease (I...
AbstractSerotypes causing invasive pneumococcal disease (IPD) in children aged <2 years in Catalonia...
Streptococcus pneumoniae serotype 1 (ST1) was an important cause of invasive pneumococ-cal disease (...
Streptococcus pneumoniae serotype 1 (ST1) was an important cause of invasive pneumococcal disease (I...
SummaryObjectivesTo describe the distribution of vaccine and non-vaccine pneumococcal serotypes from...
Background: The objective of this study is to describe incidence and shifts of serotype and clonal d...
The aim of this study was to study the serotypes and clonal diversity of pneumococci causing invasiv...
The goal of this study was to investigate the distribution of serotypes and clonal composition of St...
Serotypes/genotypes causing invasive pneumococcal disease (IPD) in adults are determined by vaccinat...
Background: Recently, the 13-valent pneumococcal conjugate vaccine (PCV13) has been recommended for ...
AbstractThe implementation of the seven-valent pneumococcal conjugate vaccine, PCV7, has resulted in...
<div><p>A prospective laboratory-based multicenter study that collected all adult invasive pneumococ...
A prospective laboratory-based multicenter study that collected all adult invasive pneumococcal dise...
AbstractThe present study evaluated changes in the incidence of invasive pneumococcal disease (IPD) ...
Streptococcus pneumoniae serotype 1 (ST1) was an important cause of invasive pneumococcal disease (I...
Streptococcus pneumoniae serotype 1 (ST1) was an important cause of invasive pneumococcal disease (I...
AbstractSerotypes causing invasive pneumococcal disease (IPD) in children aged <2 years in Catalonia...
Streptococcus pneumoniae serotype 1 (ST1) was an important cause of invasive pneumococ-cal disease (...
Streptococcus pneumoniae serotype 1 (ST1) was an important cause of invasive pneumococcal disease (I...
SummaryObjectivesTo describe the distribution of vaccine and non-vaccine pneumococcal serotypes from...